Are you a Knight ADRC affiliated researcher with a news article you would like us to post?
Contact Us
Sleep aid blocks neurodegeneration in mice (Links to an external site)
Lemborexant, similar sleep drugs show promise in treating disorders related to tau, such as Alzheimer’s disease
Drug to slow Alzheimer’s well tolerated outside of clinical trial setting (Links to an external site)
In a recent study, researchers at WashU Medicine found adverse events were rare and manageable among clinic patients with very mild or mild Alzheimer’s disease who received lecanemab infusions at the Memory Diagnostic Center at WashU Medicine.
Most people say they want to know their risk for Alzheimer’s dementia, fewer follow through (Links to an external site)
Among reasons for declining, research participants say knowing would be a burden to themselves, family members
Faster, cheaper, better: the rise of blood tests for Alzheimer’s (Links to an external site)
Circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.
The unusual genetic inheritance that could change Alzheimer’s treatment (Links to an external site)
The genes of a Colombian woman who beat the odds might lead to a new way to tackle the disease.